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INTRODUCTION 
Macular pigment (MP), which is composed of three dietary carotenoids, 
lutein (L), zeaxanthin (Z) and meso-zeaxanthin (MZ), is predominantly 
located at the site of maximum visual acuity in the human retina. MP 
absorbs short wavelength light prior to photoreceptor stimulation. Filtering 
such defocused short wavelength (blue) light could enhance visual 
performance by reducing the effects of chromatic aberration and light 
scatter.1 This hypothesis, in relation to MP, remains unproven and poorly 
investigated to date. 
 
 
 
 
 
 
 
 
 
PURPOSE 
The Collaborative Optical Macular Pigment ASsessment Study 
(COMPASS) is a double blind, placebo controlled and randomized clinical 
trial, designed to investigate whether MP optical density (MPOD) 
influences spatial vision and visual comfort by means of selective short 
wavelength light absorption prior to photoreceptor light capture. 
 
SUBJECTS and METHODS 
We recruited 142 young healthy subjects (mean ± SD age = 28.85 ± 6.37 
years). The spatial profile of MPOD was assessed by customized 
heterochromatic flicker photometry (cHFP), which has been shown to be 
a reliable and repeatable method of quantifying MPOD.3 Visual 
performance was assessed using visual acuity, mesopic and photopic 
contrast sensitivity, glare sensitivity and photostress recovery time 
measures. Each subject also completed a visual performance 
questionnaire, generating a performance index of the subject’s perception 
of their functional vision in terms of colour, acuity, glare, light/dark 
adaptation and daily visual tasks.  
 
MPOD measurement 
MPOD measurements were obtained by cHFP (using the Macular 
DensitometerTM) at five loci (0.25º, 0.50º, 1º, 1.75º and 3º of retinal 
eccentricity), with a reference point at 7º, to generate a complete spatial 
profile of MP. 
 
Best corrected visual acuity (BCVA) 
BCVA was assessed using a computer-generated LogMAR, high contrast 
chart, employing a SLOAN ETDRS letterset. A visual acuity rating (VAR) 
was computed to quantify precise acuity limits. 
 
 
    
        
        
        
      
        
      
      
    
      
    
    
      
      
      
      
  
 
Contrast sensitivity function (CSF) 
Mesopic (3 cd/m2) and photopic (100cd/m2) CSF curves were plotted using 
spatial frequencies of 1 cycle per degree (cpd), 4.1 cpd, 7.5 cpd, 11.8 cpd 
and 20.7 cpd. Gabor stimuli were displayed on a CRT monitor and 
sensitivities were determined using a linear staircase procedure. 
 
Glare sensitivity 
Mesopic (3 cd/m2) and photopic (85 cd/m2) contrast sensitivity was also 
tested under glare conditions using a sine grating functional acuity contrast 
test, and a radial glare source. CSF curves were plotted using spatial 
frequencies of 1.5 cpd, 3 cpd, 6 cpd, 12 cpd and 18 cpd. Glare effects on 
the CSF were determined for medium (35 Lux) and high (128 Lux) glare 
intensities. 
 
Photostress Recovery Time (PRT)  
PRT was evaluated using a previously described macular automated  
photostress test4  using a Humphrey 745 visual field analyzer.  
 
RESULTS 
These results represent the baseline findings from COMPASS. Mean ± SD 
MPOD obtained at peak (0.25º eccentricity) was 0.48 ± 0.19. There was a 
statistically significant positive relationship between BCVA and MPOD at all 
retinal eccentricities (r = 0.236 to 0.354, p < 0.01) [Figures 2 and Figure 3 
illustrate the relationship at 0.25º and 0.50º respectively]. 
 
 
There was an inverse relationship between mesopic contrast sensitivity 
under glare conditions for all spatial frequencies and MPOD at all 
degrees of retinal eccentricity, but was not statistically significant (p > 
0.05). 
 
There was no statistically significant relationship observed between 
MPOD and any of the functional aspects of subjective visual function 
questionnaire (r = -0.188 to 0.148, p > 0.05). There was also no 
statistically significant relationship observed between MPOD and PRT.  
(r = 0.002 to 0.102, p > 0.05).  
 
    CONCLUSION 
 Given its short wavelength absorption characteristics and central, 
prereceptorial location [see Figure 1], MP exhibits ideal properties to 
optimize visual performance. Visual performance, as assessed by visual 
acuity and contrast sensitivity measures, does appear to be influenced by 
MPOD. Photostress recovery and visual performance under glare conditions 
however show no significant relationship with MPOD.  
 
 The lack of consistency among the results possibly reflects the inherent 
difficulty associated with efforts to clarify the role of MP with respect to visual 
performance using a cross sectional methodology. A placebo controlled, 
randomized MP supplementation clinical trial, has the capacity to more 
adequately address the critical research question. 
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Figure 1. 
Figure 3. 
There was a statistically significant positive relationship between mesopic 
and photopic contrast sensitivities and MPOD, but confined to the central 
0.50° of retinal eccentricity (mesopic contrast sensitivity @ 7.5 cpd, 11.8 
cpd and MPOD at 0.25º, 0.50º: r = 0.171 to 0.210, p < 0.05; photopic 
contrast sensitivity @ 1.0 cpd, 7.5 cpd, 11.8 cpd and MPOD at 0.25º, 
0.50º: r = 0.174 to 0.197, p < 0.05; [Figures 4 and 5 illustrate the 
relationship between MPOD at 0.25º and both mesopic and photopic 
contrast sensitivity at 7.5cpd respectively].  
 
 
 
 
Figure 4. 
Figure 2. 
Figure 5. 
Central, pre-receptoral retinal location of MP. Adapted from 
Trieschmann et al., 20082 
Email:  mchaitanya@wit.ie 
